Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: Results of a retrospective survey

European Journal of Cancer

Volumn 37, Issue 13, 2001, Pages 1617-1623

  Coiffier, B ^a   Guastalla, J P ^b   Pujade Lauraine, E ^c   Bastit, P ^d  

^a HOSPICES CIVILS DE LYON   (France)

^b CENTRE LÉON BÉRARD   (France)

^c HÔTEL DIEU   (France)

^d CENTRE HENRI BECQUEREL   (France)

Author keywords

Anaemia; Epoetin alfa; Erythropoietin; Non platinum chemotherapy; Risk factors

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PACLITAXEL; RECOMBINANT ERYTHROPOIETIN; VINBLASTINE; VINCRISTINE;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; BREAST CARCINOMA; CANCER LOCALIZATION; COLORECTAL CARCINOMA; EARLY DIAGNOSIS; FRANCE; HEALTH SURVEY; HEMOGLOBIN DETERMINATION; HODGKIN DISEASE; HUMAN; LUNG CARCINOMA; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TIME;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034884692     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00169-1     Document Type: Article

References (19)

1. Factors influencing quality of life in cancer patients: Anemia and fatigue
2. Anemia in cancer patients
3. Transfusion medicine (first of two parts) - Blood transfusion
4. Erythropoietin therapy in cancer patients
5. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: Results of double-blind and open-label follow-up studies
6. Erythropoietin for anaemia in cancer patients
7. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life similar to three-times-weekly dosing
8. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: A prospective, randomized, double-blind placebo-controlled multicenter study
9. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
10. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
11. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy
12. Identifying hemoglobin level for optimal quality of life: Results of an incremental analysis
13. Chemotherapy-induced anemia in adults: Incidence and treatment
14. Special report: Transfusion risks
15. Effects of transfusion on immune function. Cancer recurrence and infection
16. Use of blood transfusion in management of anemia
17. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
18. Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia
19. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer